Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Predictors of Failure after DeVega Repair for Functional Tricuspid Regurgitation

View through CrossRef
Background: Untreated tricuspid regurgitation during mitral valve surgery may progress to severe symptomatic tricuspid regurgitation. Concomitant repair may increase the operative risk; however, re-operative tricuspid valve surgery is a high-risk procedure. This study's objective was to identify the predictors of DeVega repair failure in patients with functional tricuspid regurgitation and concomitant mitral valve surgery. Methods: This research is a retrospective comparative study that included 140 patients who underwent tricuspid valve repair concomitant with mitral valve replacement. We divided the patients into two groups; the first group (n=106) included patients with no DeVega failure at six-months follow-up (The sustained repair group). The second group included 34 patients who developed moderate or higher TR after the DeVega and was named the failed repair group. Results: The demographic data and comorbidities were not statistically different between both groups. The preoperative atrial fibrillation (73 (69%) vs. 30 (88%)’ p= 0.027) pulmonary artery pressure (64.8±3.6 vs. 81±6.5 mmHg; p= 0.02), right ventricular dimension (4.85±0.24 vs. 5.23±0.37 cm; p= 0.03), and time between the indication of surgery and operation (8.3 ± 3.1 vs. 14.7 ± 5.4 months; p = 0.003) were higher in patients with failed DeVega repair. There was no statistically significant difference regarding the mean bypass time, cross-clamp time, ICU and hospital stay, and postoperative complications between both groups. Predictors of failure after six months were preoperative heart failure (OR: 15.4 (95% CI: 3- 92.3); p= 0.003), long time between diagnosis and surgery (OR: 12.3 (95% CI: 2.1- 84.7); p= 0.007), and postoperative severe pulmonary hypertension (OR: 24.7 (95% CI: 3.1- 199.6); p= 0.003). Conclusions: DeVega repair is associated with a high failure rate after six months. The study of predictors of failure could change our management plans to reach the best results for repair.
Title: Predictors of Failure after DeVega Repair for Functional Tricuspid Regurgitation
Description:
Background: Untreated tricuspid regurgitation during mitral valve surgery may progress to severe symptomatic tricuspid regurgitation.
Concomitant repair may increase the operative risk; however, re-operative tricuspid valve surgery is a high-risk procedure.
This study's objective was to identify the predictors of DeVega repair failure in patients with functional tricuspid regurgitation and concomitant mitral valve surgery.
Methods: This research is a retrospective comparative study that included 140 patients who underwent tricuspid valve repair concomitant with mitral valve replacement.
We divided the patients into two groups; the first group (n=106) included patients with no DeVega failure at six-months follow-up (The sustained repair group).
The second group included 34 patients who developed moderate or higher TR after the DeVega and was named the failed repair group.
Results: The demographic data and comorbidities were not statistically different between both groups.
The preoperative atrial fibrillation (73 (69%) vs.
30 (88%)’ p= 0.
027) pulmonary artery pressure (64.
8±3.
6 vs.
81±6.
5 mmHg; p= 0.
02), right ventricular dimension (4.
85±0.
24 vs.
5.
23±0.
37 cm; p= 0.
03), and time between the indication of surgery and operation (8.
3 ± 3.
1 vs.
14.
7 ± 5.
4 months; p = 0.
003) were higher in patients with failed DeVega repair.
There was no statistically significant difference regarding the mean bypass time, cross-clamp time, ICU and hospital stay, and postoperative complications between both groups.
Predictors of failure after six months were preoperative heart failure (OR: 15.
4 (95% CI: 3- 92.
3); p= 0.
003), long time between diagnosis and surgery (OR: 12.
3 (95% CI: 2.
1- 84.
7); p= 0.
007), and postoperative severe pulmonary hypertension (OR: 24.
7 (95% CI: 3.
1- 199.
6); p= 0.
003).
Conclusions: DeVega repair is associated with a high failure rate after six months.
The study of predictors of failure could change our management plans to reach the best results for repair.

Related Results

When should the tricuspid valve be repaired during mitral valve repair?
When should the tricuspid valve be repaired during mitral valve repair?
Purpose of review Management of tricuspid regurgitation and annular dilation during mitral valve repair remains controversial. We review the latest evidence on indicati...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Concomitant tricuspid repair in mitral regurgitation surgery: a systematic review and meta-analysis
Concomitant tricuspid repair in mitral regurgitation surgery: a systematic review and meta-analysis
Abstract Background Tricuspid Regurgitation (TR) is common in patients with severe mitral disease. However, the evidence is insu...
Midterm Results of Mitral Valve Repair for Atrial Functional Mitral Regurgitation: A Retrospective Study
Midterm Results of Mitral Valve Repair for Atrial Functional Mitral Regurgitation: A Retrospective Study
Abstract Background: Annular dilation by left atrial remodeling is considered the main cause of atrial function mitral regurgitation. Although acceptable outcomes have been...
Improvement of Tricuspid Regurgitation after Pulmonary Thromboendarterectomy
Improvement of Tricuspid Regurgitation after Pulmonary Thromboendarterectomy
Chronic thromboembolic pulmonary hypertension causes right ventricular dilation with various degrees of tricuspid regurgitation, leading to right heart failure. Pulmonary thromboen...
Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11–14 weeks of gestation
Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11–14 weeks of gestation
Objective: To analyse patient data to elucidate the apparent association between an abnormal karyotype and tricuspid regurgitation found during fetal echocardiography at early gest...
Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis
Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis
Abstract Background In recent years, due to the increase in intravenous drug injection and intracardiac and vascular interventional treatments among drug users, infective ...

Back to Top